Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 1301 - 1400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1301 | 25804349 |
EU |
22 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Hepatic failure, Diabetes mellitus, Osteoporosis, Pruritus, Off label use, |
||||
SULFASALAZINE, |
||||
| 1302 | 25804362 |
US |
69 | 1 |
Dry mouth, Erythema, Pruritus, Urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1303 | 25804553 |
US |
40 | 1 |
Stress, Sleep deficit, Pruritus, Neurodermatitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1304 | 25804630 |
CA |
62 | 1 |
Ureteric cancer, Erythema, Rash, Pruritus, |
||||
USTEKINUMAB, |
||||
| 1305 | 25804709 |
US |
||
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1306 | 25804757 |
US |
79 | 2 |
Colon operation, Erythema, Rhinorrhoea, Pruritus, Skin burning sensation, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1307 | 25804784 |
US |
56 | 2 |
Rash, Pruritus, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1308 | 25806635 |
76 | 2 | |
Infusion related reaction, Urticaria, Pruritus, Erythema, |
||||
HUMAN IMMUNOGLOBULIN G, PREGABALIN, MONTELUKAST SODIUM, MONTELUKAST, LISINOPRIL, ROSUVASTATIN, CARVEDILOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FUROSEMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, EZETIMIBE, |
||||
| 1309 | 25806723 |
|||
Pruritus, Urticaria, |
||||
| 1310 | 25807267 |
74 | 2 | |
Pruritus, Eye swelling, Swelling face, |
||||
LENALIDOMIDE, |
||||
| 1311 | 25808486 |
12 | 1 | |
Pruritus, Headache, Abdominal pain, Pyrexia, Erythema, Hypersensitivity, |
||||
GIVINOSTAT, |
||||
| 1312 | 25808487 |
70 | 2 | |
Infusion related reaction, Pruritus, Nausea, Back pain, Neck pain, Hyperhidrosis, Hyperventilation, Retching, Diarrhoea, Respiratory tract congestion, |
||||
DALBAVANCIN, DALBAVANCIN, |
||||
| 1313 | 25799436 |
US |
46 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1314 | 25799451 |
US |
63 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1315 | 25799452 |
US |
59 | 1 |
Pruritus, Rebound effect, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1316 | 25799466 |
US |
46 | 2 |
Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LORAZEPAM, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, |
||||
| 1317 | 25799480 |
US |
3 | 1 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1318 | 25799494 |
US |
1 | |
Fatigue, Cough, Erythema, Pruritus, Headache, Back pain, Diarrhoea, Rebound effect, |
||||
DUPILUMAB, |
||||
| 1319 | 25799514 |
US |
50 | 2 |
Dermatitis atopic, Blister, Pruritus, Erythema, Rebound effect, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1320 | 25799517 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1321 | 25799526 |
US |
1 | |
Influenza, Skin laceration, Gastritis, Pruritus, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, CARVEDILOL, ROSUVASTATIN, |
||||
| 1322 | 25799536 |
US |
26 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1323 | 25799562 |
GB |
32 | 2 |
Oral allergy syndrome, Oedema mucosal, Lip swelling, Rash, Pruritus, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, FLUCONAZOLE, MICONAZOLE, MICONAZOLE NITRATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1324 | 25799571 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1325 | 25799573 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, ABALOPARATIDE, |
||||
| 1326 | 25799585 |
US |
2 | 1 |
Rebound eczema, Pruritus, Miliaria, Rebound effect, Skin infection, Rebound effect, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1327 | 25799642 |
US |
1 | 1 |
Eczema, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1328 | 25799724 |
US |
2 | |
Eczema, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1329 | 25799730 |
US |
56 | 2 |
Dermatitis atopic, Pruritus, Blister, Skin fissures, Pain of skin, |
||||
DUPILUMAB, |
||||
| 1330 | 25799732 |
US |
35 | 2 |
Influenza, Nasopharyngitis, Pruritus, Injection site pain, Injection site swelling, Incorrect dose administered, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, COLESTIPOL HYDROCHLORIDE, ROFLUMILAST, CLINDAMYCIN HYDROCHLORIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, POLYETHYLENE GLYCOL 3350, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1331 | 25799755 |
US |
80 | 1 |
Lymphadenopathy, Malaise, Eczema, Pruritus, Rash, Rebound effect, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1332 | 25799758 |
US |
64 | 2 |
Energy increased, Diarrhoea, Pruritus, |
||||
DUPILUMAB, |
||||
| 1333 | 25799770 |
US |
18 | 2 |
Pruritus, Abdominal discomfort, Vomiting, Pain, Hypersensitivity, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1334 | 25799796 |
US |
57 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Drug effective for unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, GUSELKUMAB, |
||||
| 1335 | 25799810 |
US |
73 | 1 |
Eczema, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1336 | 25799813 |
US |
48 | 1 |
Eczema, Rash, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1337 | 25799815 |
US |
2 | 2 |
Eye pain, Pruritus, Wrong technique in device usage process, |
||||
DUPILUMAB, |
||||
| 1338 | 25799819 |
US |
39 | 2 |
Hypothyroidism, Asthma, Sleep apnoea syndrome, Migraine, Aphthous ulcer, Pruritus, |
||||
DUPILUMAB, |
||||
| 1339 | 25799845 |
US |
84 | 2 |
Drug hypersensitivity, Discomfort, Rash macular, Urticaria, Pruritus, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1340 | 25799853 |
US |
||
Erythema, Pruritus, |
||||
TIRZEPATIDE, |
||||
| 1341 | 25798342 |
CA |
||
Blood pressure fluctuation, Condition aggravated, Ear disorder, Ear pruritus, Fatigue, Nephrolithiasis, Oropharyngeal pain, Pharyngeal swelling, Throat irritation, Pain, Malaise, COVID-19, Headache, Infection, Insomnia, Kidney infection, Nausea, Pneumonia fungal, Pruritus, Rash, Respiratory tract infection, Skin infection, Viral infection, Flushing, Intentional product use issue, Inappropriate schedule of product administration, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, AMLODIPINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1342 | 25798454 |
US |
||
Pruritus, |
||||
GLECAPREVIR AND PIBRENTASVIR, |
||||
| 1343 | 25798500 |
US |
2 | |
Pruritus, Blister, |
||||
DUPILUMAB, |
||||
| 1344 | 25798525 |
US |
||
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1345 | 25798544 |
US |
57 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1346 | 25798556 |
US |
||
Pruritus, Dry skin, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1347 | 25798576 |
US |
24 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1348 | 25798599 |
US |
64 | 2 |
Dermal cyst, Skin swelling, Pruritus, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 1349 | 25798600 |
US |
44 | 1 |
Pruritus, Dry eye, |
||||
DUPILUMAB, |
||||
| 1350 | 25798691 |
US |
||
Rash, Swelling of eyelid, Skin swelling, Pruritus, |
||||
NEMOLIZUMAB-ILTO, ERGOCALCIFEROL, |
||||
| 1351 | 25798782 |
US |
2 | |
Hot flush, Pruritus, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, VILAZODONE HYDROCHLORIDE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RIVAROXABAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FUROSEMIDE, VITAMIN E, MAGNESIUM, |
||||
| 1352 | 25798787 |
US |
72 | 2 |
Abdominal discomfort, Abdominal pain, Diarrhoea, Pruritus, Rash, |
||||
| 1353 | 25798838 |
US |
||
Pruritus, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1354 | 25798937 |
US |
60 | 2 |
Constipation, Skin lesion, Joint swelling, Rash macular, Pruritus, Peripheral swelling, Dizziness, Incorrect dose administered, |
||||
DUPILUMAB, MEPOLIZUMAB, |
||||
| 1355 | 25798954 |
US |
||
Pruritus, Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1356 | 25798956 |
EU |
2 | |
Loss of personal independence in daily activities, Visual acuity reduced, Visual impairment, Chromatopsia, Visual field defect, Skin burning sensation, Colour blindness acquired, Photopsia, Eye swelling, Pruritus, Rash, Nausea, |
||||
PREGABALIN, METHYLPREDNISOLONE, CALCIUM, LEVOTHYROXINE, MEDROXYPROGESTERONE ACETATE, OXYCODONE, RETINOL, |
||||
| 1357 | 25799024 |
US |
15 | 2 |
Pruritus, Rebound effect, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1358 | 25799046 |
US |
2 | |
Chronic lymphocytic leukaemia, Lymphoma, Sjogren^s syndrome, Seasonal allergy, Cough, Abdominal pain upper, Pruritus, Erythema, Dry mouth, Fatigue, Therapy partial responder, Product dose omission issue, Incorrect product administration duration, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, FUROSEMIDE, POTASSIUM CHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TADALAFIL, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, HYDROXYUREA, MACITENTAN, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, TOLTERODINE TARTRATE, TOLTERODINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, RITUXIMAB, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CEPHALEXIN, ONDANSETRON HYDROCHLORIDE, PREGABALIN, ZANUBRUTINIB, |
||||
| 1359 | 25799063 |
US |
||
Pruritus, Therapeutic product effect decreased, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1360 | 25799064 |
US |
2 | |
Dark circles under eyes, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1361 | 25799103 |
US |
58 | 2 |
Anxiety, Confusional state, Pruritus, |
||||
HYDROXYCHLOROQUINE, |
||||
| 1362 | 25799118 |
US |
72 | 1 |
Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1363 | 25799119 |
US |
78 | 2 |
Alopecia, Pruritus, Headache, Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1364 | 25799179 |
US |
||
Dry skin, Pruritus, Thirst, Product dose omission issue, |
||||
TOLVAPTAN, TOLVAPTAN, ERGOCALCIFEROL, FISH OIL, IRON, TOLVAPTAN, |
||||
| 1365 | 25799256 |
US |
39 | 2 |
Pruritus, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, |
||||
| 1366 | 25799258 |
US |
56 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1367 | 25799276 |
US |
31 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1368 | 25799298 |
US |
4 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1369 | 25799303 |
US |
73 | 1 |
Urinary tract infection, Pruritus, |
||||
DUPILUMAB, |
||||
| 1370 | 25799308 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1371 | 25799366 |
US |
2 | |
Pruritus, Rebound effect, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1372 | 25799404 |
TW |
79 | 2 |
Angioedema, Swelling, Pruritus, Swelling of eyelid, Allergic oedema, Drug hypersensitivity, |
||||
BRIMONIDINE TARTRATE, BIMATOPROST, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, |
||||
| 1373 | 25799416 |
US |
16 | 1 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1374 | 25799423 |
US |
73 | 2 |
Eczema, Pruritus, Rash, Skin haemorrhage, Skin fissures, |
||||
DUPILUMAB, |
||||
| 1375 | 25802463 |
64 | 2 | |
Withdrawal syndrome, Nausea, Headache, Head discomfort, Tremor, Muscle spasms, Akathisia, Photophobia, Anxiety, Agitation, Depersonalisation/derealisation disorder, Derealisation, Arthralgia, Fatigue, Lethargy, Insomnia, Formication, Pruritus, Skin burning sensation, Negative thoughts, Suicidal ideation, Loss of personal independence in daily activities, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VALSARTAN, VALSARTAN ORAL, BACLOFEN, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 1376 | 25793607 |
US |
||
Dry skin, Pruritus, Eczema, Nightmare, Rhinorrhoea, Illness, Pyrexia, Fatigue, Visual impairment, |
||||
CYCLOSPORINE, DUPILUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 1377 | 25793704 |
US |
12 | 1 |
Dry skin, Skin fissures, Condition aggravated, Erythema, Condition aggravated, Pruritus, |
||||
DUPILUMAB, |
||||
| 1378 | 25793756 |
US |
47 | 1 |
Rash erythematous, Skin burning sensation, Condition aggravated, Pruritus, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1379 | 25793757 |
US |
42 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1380 | 25793784 |
US |
16 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 1381 | 25793785 |
US |
86 | 1 |
Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 1382 | 25793801 |
US |
2 | |
Accidental exposure to product, Pruritus, Underdose, |
||||
GUSELKUMAB, |
||||
| 1383 | 25793845 |
US |
2 | |
Pruritus, Off label use, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1384 | 25793876 |
US |
1 | |
Pruritus, Therapeutic product effect incomplete, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1385 | 25793901 |
US |
81 | 1 |
Pruritus, Hot flush, |
||||
RELUGOLIX, RELUGOLIX, PROPYLENE GLYCOL, |
||||
| 1386 | 25793996 |
US |
||
Yellow skin, Dry skin, Pruritus, |
||||
RESMETIROM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1387 | 25794024 |
BR |
2 | |
Swelling, Pruritus, Off label use, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, |
||||
| 1388 | 25794047 |
US |
||
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1389 | 25794095 |
CA |
50 | 1 |
Erythema, Dyspnoea, Skin burning sensation, Chills, Pruritus, Back pain, |
||||
CARBOPLATIN, PACLITAXEL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, PEMBROLIZUMAB, |
||||
| 1390 | 25794149 |
CA |
77 | 2 |
Pruritus, Jaundice, Hepatic failure, |
||||
PREDNISONE, AMOXICILLIN AND CLAVULANATE POTASSIUM, ALLOPURINOL, CANDESARTAN, PANTOPRAZOLE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, HYDROCODONE BITARTRATE, LACTULOSE, CICLESONIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, CYANOCOBALAMIN, |
||||
| 1391 | 25794232 |
US |
32 | 2 |
Pruritus, |
||||
OCRELIZUMAB, |
||||
| 1392 | 25794289 |
US |
||
Pruritus, Skin irritation, |
||||
NIMODIPINE, NIMODIPINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 1393 | 25794291 |
US |
2 | |
Rash, Pruritus, |
||||
HYDROCHLOROTHIAZIDE, |
||||
| 1394 | 25794344 |
EU |
57 | 2 |
Rash macular, Pruritus, |
||||
RIVAROXABAN, |
||||
| 1395 | 25794369 |
US |
90 | 2 |
Cystitis, Blood pressure increased, Pruritus, Therapeutic response unexpected, Inappropriate schedule of product administration, |
||||
MIRABEGRON, MIRABEGRON, |
||||
| 1396 | 25794505 |
EU |
42 | 1 |
Oedema peripheral, Rash, Pruritus, Scrotal swelling, Burning sensation, |
||||
| 1397 | 25794506 |
US |
2 | |
Pruritus, |
||||
DAPAGLIFLOZIN, TREPROSTINIL, |
||||
| 1398 | 25794554 |
US |
||
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1399 | 25794630 |
US |
59 | 1 |
Pruritus, Urticaria, |
||||
ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE, |
||||
| 1400 | 25794691 |
US |
2 | |
Abdominal discomfort, Illness, Pruritus, Headache, Abdominal pain upper, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30